Global Acne Market 2014-2018
Published: Technavio No of pages: 72
Date: November 2014
Explore all reports for “Healthcare” market @ http://www.reportsandintelligence.com/healthcare-market-report
Acne is one of the common dermatological disorders. Acne, or acne vulgaris is an inflammatory disorder of the skin which affects people of almost all age groups. The exact etiology of acne is not fully understood. Although acne does not present a serious threat to health, severe acne can not only be painful, but also affect a patient’s quality of life. Topical medications, oral medications, or a combination of all are some of the treatment options available for acne. TechNavio's analysts forecast the Global Acne market to grow at a CAGR of 4.07 percent over the period 2013-2018. Covered in this Report The Global Acne market can be divided into seven segments: Antibiotics, AntiInflammatories, Antimicrobials, Combination Medications, Hormonal Agents, Oral Retinoid, and Topical Retinoid. This report covers the present scenario and the growth prospects of the Global Acne market for the period 2013–2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs and topical creams used in the treatment of acne that are available in the market. TechNavio's report, the Global Acne Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Acne market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key Regions • Americas
• EMEA • APAC Key Vendors • Actavis • Allergen • Galderma • Stiefel Laboratories • Valeant Pharmaceuticals International Other Prominent Vendors • Andro Science • Bayer • Cipher Pharmaceuticals • Cosmo Pharmaceuticals • Elorac • Foamix Pharmaceuticals • Helix BioMedix • Hygeia Therapeutics • IMTM • J&J • Mylan Pharmaceuticals • NanoBio • NovaLead Pharma • F. Hoffmann-La Roche
Market Driver • Significant Unmet Needs • For a full, detailed list, view our report Market Challenge • High Cost of Acne Drugs • For a full, detailed list, view our report Market Trend • Increased Focus on Combination Therapies
• For a full, detailed list, view our report Key Questions Answered in this Report • What will the market size be in 2018 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors?
Detailed report @: http://www.reportsandintelligence.com/globalacne-2014-2018-market
Table of Content 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 03.1 Market Overview 03.2 Product Offerings 04. Market Research Methodology 04.1 Market Research Process 04.2 Research Methodology 05. Introduction 06. Market Landscape 06.1 Market Overview 06.2 Market Size and Forecast 07. Implications of Acne 07.1 Five Forces Analysis 08. Types and Characteristics of Acne 09. Competitive Assessment of Marketed Products 10. Rate of Incidence and Prevalence 10.1.1 US 10.1.2 UK 11. Market Segmentation by Category
12. Geographical Segmentation 13. Buying Criteria 14. Market Growth Drivers 15. Drivers and their Impact 16. Market Challenges 17. Impact of Drivers and Challenges 18. Market Trends 19. Trends and their Impact 20. Vendor Landscape 20.1 Competitive Scenario 20.1.1 Key News 20.1.2 Mergers and Acquisitions 20.2 Market Share Analysis 2013 20.3 Other Prominent Vendors
Enquire about Report @: http://www.reportsandintelligence.com/enquire-aboutreport/150004 21. Key Vendor Analysis 21.1 Actavis plc 21.1.1 Key Facts 21.1.2 Business Description 21.1.3 Business Segmentation 21.1.4 Business Segmentation by Revenue 2012 and 2013 21.1.5 Sales by Geography 21.1.6 Business Strategy 21.1.7 Key Information 21.1.8 SWOT Analysis 21.2 Allergan Inc. 21.2.1 Key Facts 21.2.2 Business Description 21.2.3 Business Segmentation 21.2.4 Revenue by Business Segmentation 21.2.5 Revenue Comparison 2011-2013 21.2.6 Revenue by Geographical Segmentation 21.2.7 Business Strategy 21.2.8 Key Developments
21.2.9 SWOT Analysis 21.3 Galderma 21.3.1 Key Facts 21.3.2 Business Overview 21.3.3 Product Segmentation by Revenue 2013 21.3.4 Geographical Segmentation by Revenue 2013 21.3.5 Business Strategy 21.3.6 Recent Developments 21.3.7 SWOT Analysis 21.4 Stiefel Laboratories 21.4.1 Key Facts 21.4.2 Business Overview 21.4.3 Product Segmentation 21.4.4 Geographical Segmentation by Revenue 2013 21.4.5 Business Strategy 21.4.6 Recent Developments 21.4.7 SWOT Analysis 21.5 Valeant Pharmaceuticals International Inc. 21.5.1 Key Facts 21.5.2 Business Overview 21.5.3 Business Segmentation by Revenue 2013 21.5.4 Business Segmentation by Revenue 2012 and 2013 21.5.5 Sales by Geography 21.5.6 Business Strategy 21.5.7 Key Developments 21.6 SWOT Analysis
Get detailed TOC at: http://www.reportsandintelligence.com/global-acne-2014-2018market/table-of-contents
Contact Us: Deep Joshi 5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States Direct: +1 (617) 674-4143 Toll Free: +1 (855) 711-1555 Fax: +1 (855) 550-5975 Email us: sales@reportsandintelligence.com Web: http://www.reportsandintelligence.com
Follow us on: